MedTrace Logo

Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement

NCT02957643 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-07-29

No results posted yet for this study

Summary

The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment.

Conditions

  • Prevention of Anemia

Interventions

DRUG

Iron

oral treatment

Sponsors & Collaborators

  • Hippocration General Hospital

    lead OTHER

Principal Investigators

  • PANAGIOTIS MATSOUKATIDIS, MD,Msc · Aristotle University Of Thessaloniki

  • CHARALABOS KOLVATZIS, MD · Aristotle University Of Thessaloniki

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-09-30
Completion
2017-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02957643 on ClinicalTrials.gov